|
Name |
Isochromophilone VI
|
Molecular Formula | C23H28ClNO5 | |
IUPAC Name* |
[(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate
|
|
SMILES |
CC[C@H](C)/C=C(\C)/C=C/C1=CC2=C(C(=O)[C@](C(=O)C2=CN1CCO)(C)OC(=O)C)Cl
|
|
InChI |
InChI=1S/C23H28ClNO5/c1-6-14(2)11-15(3)7-8-17-12-18-19(13-25(17)9-10-26)21(28)23(5,30-16(4)27)22(29)20(18)24/h7-8,11-14,26H,6,9-10H2,1-5H3/b8-7+,15-11+/t14-,23+/m0/s1
|
|
InChIKey |
ZQLIAKJHIRHCFA-XIIQHIPDSA-N
|
|
Synonyms |
Isochromophilone VI; 167173-91-3; [(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate; FO 3216IV; FO-3216 VI; CHEMBL5072126; DTXSID801347091; ZINC13905030; Isochromophilone VI, >=90% (LC/MS-ELSD); 6,8(2H,7H)-Isoquinolinedione, 7-(acetyloxy)-5-chloro-3-((1E,3E,5S)-3,5-dimethyl-1,3-heptadienyl)-2-(2-hydroxyethyl)-7-methyl-, (7R)-; 6,8(2H,7H)-Isoquinolinedione, 7-(acetyloxy)-5-chloro-3-(3,5-dimethyl-1,3-heptadienyl)-2-(2-hydroxyethyl)-7-methyl-, (R-(R*,S*-(E,E)))-; NCGC00347765-02![(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate
|
|
CAS | 167173-91-3 | |
PubChem CID | 6443570 | |
ChEMBL ID | CHEMBL5072126 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 433.9 | ALogp: | 4.2 |
HBD: | 1 | HBA: | 6 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 83.9 | Aromatic Rings: | 2 |
Heavy Atoms: | 30 | QED Weighted: | 0.366 |
Caco-2 Permeability: | -4.674 | MDCK Permeability: | 0.00002810 |
Pgp-inhibitor: | 0.969 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.015 |
Blood-Brain-Barrier Penetration (BBB): | 0.275 | Plasma Protein Binding (PPB): | 79.85% |
Volume Distribution (VD): | 2.084 | Fu: | 20.19% |
CYP1A2-inhibitor: | 0.725 | CYP1A2-substrate: | 0.198 |
CYP2C19-inhibitor: | 0.741 | CYP2C19-substrate: | 0.811 |
CYP2C9-inhibitor: | 0.762 | CYP2C9-substrate: | 0.436 |
CYP2D6-inhibitor: | 0.193 | CYP2D6-substrate: | 0.124 |
CYP3A4-inhibitor: | 0.921 | CYP3A4-substrate: | 0.597 |
Clearance (CL): | 1.822 | Half-life (T1/2): | 0.921 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.905 |
Drug-inuced Liver Injury (DILI): | 0.976 | AMES Toxicity: | 0.764 |
Rat Oral Acute Toxicity: | 0.252 | Maximum Recommended Daily Dose: | 0.877 |
Skin Sensitization: | 0.785 | Carcinogencity: | 0.882 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.013 |
Respiratory Toxicity: | 0.915 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003676 | 0.845 | D05QDC | 0.220 | ||||
ENC002463 | 0.826 | D0B1IP | 0.220 | ||||
ENC006052 | 0.820 | D0WY9N | 0.217 | ||||
ENC003605 | 0.778 | D0S7WX | 0.202 | ||||
ENC006054 | 0.767 | D02DGU | 0.198 | ||||
ENC001841 | 0.689 | D0G3PI | 0.198 | ||||
ENC006053 | 0.684 | D00DKK | 0.198 | ||||
ENC004761 | 0.566 | D06BLQ | 0.194 | ||||
ENC005593 | 0.540 | D0V2JK | 0.194 | ||||
ENC006055 | 0.525 | D0L5FY | 0.190 |